These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15627672)

  • 41. Carcinoma of the esophagus.
    Parker EF; Gregorie HB; Arrants JE; Ravenel JM
    Ann Surg; 1970 May; 171(5):746-51. PubMed ID: 4192275
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer.
    Caspers RJ; Welvaart K; Verkes RJ; Hermans J; Leer JW
    Radiother Oncol; 1988 May; 12(1):15-23. PubMed ID: 2457230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of radiotherapy in the management of esophageal cancer.
    Pearson JG
    Am J Roentgenol Radium Ther Nucl Med; 1969 Mar; 105(3):500-13. PubMed ID: 4180246
    [No Abstract]   [Full Text] [Related]  

  • 44. Carcinoma of the esophagus: surgery versus radiotherapy.
    Ellis FH; Salzman FA
    Postgrad Med; 1977 Feb; 61(2):167-74. PubMed ID: 64977
    [No Abstract]   [Full Text] [Related]  

  • 45. A retrospective study of external beam radiation, neutron brachytherapy, and concurrent chemotherapy for patients with localized advanced carcinoma of the esophagus.
    Ma K; Wang Q; Li T; Liu H; Liu B; Jia X; Li S; Lang J; Zhang M
    Radiat Oncol; 2014 Dec; 9():294. PubMed ID: 25515326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
    Kumar MU; Swamy K; Supe SS; Anantha N
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiotherapy in squamous cell esophageal cancer.
    Van Den Berge D; Popowski Y; Van Lancker M; Storme G; Van Houtte P
    J Belge Radiol; 1991; 74(5):397-9. PubMed ID: 1724667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Radiotherapy of esophageal carcinoma: analysis of annual cases in multi-institutes].
    Hishikawa Y; Miura T; Tanaka S; Kamikonya N; Abe M; Takahashi M; Hiraoka M; Nishimura Y; Inoue T; Chatani M
    Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1203-10. PubMed ID: 3430014
    [No Abstract]   [Full Text] [Related]  

  • 49. Positive impact of radiation dose on disease free survival and locoregional control in postoperative radiotherapy for squamous cell carcinoma of esophagus.
    Moon S; Kim H; Chie E; Kim J; Park C
    Dis Esophagus; 2009; 22(4):298-304. PubMed ID: 19021683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Curietherapy at high dose radiation in the treatment of cancer of the esophagus].
    Claudel-Bonvoisin S; Rocher F; Arnaud MP; Salerno N; Romestaing P; Isoard B; Descos L; Gerard JP
    Gastroenterol Clin Biol; 1993; 17(10):771. PubMed ID: 8288095
    [No Abstract]   [Full Text] [Related]  

  • 51. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer.
    Taal BG; Aleman BM; Koning CC; Boot H
    Br J Cancer; 1996 Nov; 74(9):1452-7. PubMed ID: 8912544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracavitary therapy in carcinoma of the esophagus.
    Ayyagiri S
    Indian J Gastroenterol; 1991 Apr; 10(2):40-2. PubMed ID: 1710202
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus.
    Sule-Suso J; Brunt AM; Lindup R; Scoble JE
    Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):209-13. PubMed ID: 1718399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. External beam radiotherapy and intraluminal brachytherapy in advanced inoperable esophageal cancer: JIPMER experience.
    Vivekanandam S; Reddy KS; Velavan K; Balasundaram V; Ranga Rao S; Subba Rao KS; Nachiappan M
    Am J Clin Oncol; 2001 Apr; 24(2):128-30. PubMed ID: 11319284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Initial experience with telebrachytherapy treatment in palliation of advanced oesophageal cancer.
    Sur RK; Levin V; Malas S; Donde B; Ahmed N; Retter E
    S Afr J Surg; 1995 Jun; 33(2):67-9. PubMed ID: 8545726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiotherapy for esophageal carcinoma.
    Pearson JG
    World J Surg; 1981 Jul; 5(4):489-97. PubMed ID: 6172903
    [No Abstract]   [Full Text] [Related]  

  • 57. A non-randomized comparison of two radiotherapy protocols in inoperable squamous cell carcinoma of the oesophagus.
    Datta NR; Kumar S; Nangia S; Hukku S; Ayyagari S
    Clin Oncol (R Coll Radiol); 1998; 10(5):306-12. PubMed ID: 9848331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraluminal irradiation for T2M0 esophageal cancer: effect of patient selection on prognosis.
    Nakajima T; Fukuda H; Hosono M; Tsumura M; Tada T; Nishita T; Tashiro M; Hirokawa K; Onoyama Y
    Radiat Med; 1992; 10(3):123-8. PubMed ID: 1509104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The value of radiotherapy or chemotherapy after intubation for advanced esophageal carcinoma--a prospective randomized trial.
    Schmid EU; Alberts AS; Greeff F; Terblanche AP; Schoeman L; Burger W; Shiels RA; Friediger D; Van der Hoven A; Falkson G
    Radiother Oncol; 1993 Jul; 28(1):27-30. PubMed ID: 7694321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early experience with linear accelerator in carcinoma oesophagus middle third.
    Ratnam SV; Baboo HA; Sabir AA; Sharma A; Vyas R
    Indian J Chest Dis Allied Sci; 1986; 28(4):197-201. PubMed ID: 3111992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.